Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 6Juvederm Collection
02 1Synvisc
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Bone Health
Currency : USD
2014 Revenue in Millions : -5.10%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Dermatology
Currency : USD
2020 Revenue in Millions : 718
2019 Revenue in Millions : 0
Growth (%) : 100
Main Therapeutic Indication : Dermatology
Currency : USD
2021 Revenue in Millions : 1,535
2020 Revenue in Millions : 718
Growth (%) : 114
Main Therapeutic Indication : Dermatology
Currency : USD
2022 Revenue in Millions : 1,428
2021 Revenue in Millions : 1,535
Growth (%) : -7
Main Therapeutic Indication : Dermatology
Currency : USD
2023 Revenue in Millions : 1,378
2022 Revenue in Millions : 1,428
Growth (%) : -4
Main Therapeutic Indication : Dermatology
Currency : USD
2018 Revenue in Millions : 1,163
2017 Revenue in Millions : 1,042
Growth (%) : 12%
Main Therapeutic Indication : Dermatology
Currency : USD
2019 Revenue in Millions : 1,244
2018 Revenue in Millions : 1,163
Growth (%) : 7
